PACTR202401827533382
Completed
未知
Monitoring and evaluation of molecular markers drug resistance during seasonal malaria chemoprevention with sulfadoxine-pyrimethamine and amodiaquine implementation in Koutiala, Mali
AAS0 sites1,000 target enrollmentDecember 25, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- AAS
- Enrollment
- 1000
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •i. Child who received SP or AQ in the previous month;
- •ii. Child suffering from malaria diagnosed or under treatment at the time of implementation;
- •iii. Child with a known allergy to SP or AQ;
- •iv. adults never have taken SMC
Exclusion Criteria
- •1\. Known allergy to SMC medicine
- •2\. Child with severe malaria
- •3\. Child on cotrimoxazole
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Development of molecular diagnostic markers using oral fluid for diagnosis of periodontitis in diabetesDiseases of the musculo-skeletal system and connective tissueKCT0001023Asan Medical Center24
Recruiting
Not Applicable
Evaluation of molecular markers to predict the pattern of tumor recurrence and prognosis in pancreatric ductal adenocarcinomaC25Malignant neoplasm of pancreasDRKS00006179Klinik und Poliklinik für Allgemein-, Viszeral-, Tumor- und Transplantationschirurgie600
Not yet recruiting
Not Applicable
Evaluation study of biological markers involved in cardiovascular diseases in childhoodcardiovascular diseasesJPRN-UMIN000002281Kyoto university100
Recruiting
Not Applicable
Molecular markers for diagnosis and therapy response in Inflammatory Bowel diseases: A prospective population based bio-bank of inflammatory bowel disease patients in Zuid Limburg, The Netherlands.inflammatory bowel disease10017969NL-OMON50587Interne geneeskunde/Divisie MD5,000
Recruiting
Not Applicable
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDemyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDRKS00031139MPI-NAT1,000